Synovus Financial Corp United Therapeutics Corp Transaction History

Synovus Financial Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$211.82 - $248.24 $190,638 - $223,416	900 New	900 $203,000
Q4 2022 Feb 06, 2023	BUY	$205.95 - $280.43 $185,355 - $252,387	900 New	900 $250,000
Q2 2022 Aug 10, 2022	BUY	$174.81 - $241.14 $157,329 - $217,026	900 New	900 $212,000
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $202,752 - $237,688	-1,100 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$179.86 - $214.88 $197,846 - $236,368	1,100 New	1,100 $203,000
Q3 2020 Nov 09, 2020	SELL	$99.9 - $121.13 $109,890 - $133,243	-1,100 Closed	0 $0
Q3 2019 Nov 01, 2019	SELL	$74.85 - $85.99 $7,484 - $8,599	-100 Reduced 8.33%	1,100 $88,000
Q2 2019 Aug 08, 2019	SELL	$76.06 - $120.81 $193,572 - $307,461	-2,545 Reduced 99.65%	9 $1,000
Q1 2019 May 09, 2019	SELL	$107.15 - $126.84 $107,150 - $126,840	-1,000 Reduced 45.45%	1,200 $141,000
Q4 2018 Feb 07, 2019	SELL	$101.4 - $128.73 $86,190 - $109,420	-850 Reduced 27.87%	2,200 $240,000
Q3 2018 Nov 01, 2018	SELL	$113.81 - $129.46 $11,381 - $12,946	-100 Reduced 3.17%	3,050 $390,000
Q2 2018 Aug 01, 2018	SELL	$101.14 - $118.31 $8,394 - $9,819	-83 Reduced 3.3%	2,430 $271,000
Q1 2018 May 07, 2018	BUY	$107.21 - $151.94 $5,146 - $7,293	48 Added 1.95%	2,513 $280,000
Q4 2017 Feb 09, 2018	SELL	$118.58 - $151.28 $11,858 - $15,128	-100 Reduced 3.08%	3,150 $466,000
Q3 2017 Nov 13, 2017	BUY	$114.6 - $136.81 $372,450 - $444,632	3,250	3,250 $381,000

679

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.